{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T01:46:06Z","timestamp":1781228766640,"version":"3.54.1"},"reference-count":95,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["17ek0109097 & 17ek0109155"],"award-info":[{"award-number":["17ek0109097 & 17ek0109155"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.neuint.2018.11.023","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T21:33:14Z","timestamp":1543613594000},"page":"104348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Eomes-expressing T-helper cells as potential target of therapy in chronic neuroinflammation"],"prefix":"10.1016","volume":"130","author":[{"given":"Shinji","family":"Oki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neuint.2018.11.023_bib1","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.neuron.2005.03.018","article-title":"Neuronal damage in autoimmune neuroinflammation mediated by the death ligand TRAIL","volume":"46","author":"Aktas","year":"2005","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.neuint.2018.11.023_bib2","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/jnnp.2003.010090","article-title":"Multicentre, randomised, double blind, placebo controlled, phase III study of weekly, low dose, subcutaneous interferon beta-1a in secondary progressive multiple sclerosis","volume":"75","author":"Andersen","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"1","key":"10.1016\/j.neuint.2018.11.023_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/2047-9158-3-25","article-title":"Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders","volume":"3","author":"Anderson","year":"2014","journal-title":"Transl. Neurodegener."},{"issue":"9","key":"10.1016\/j.neuint.2018.11.023_bib4","doi-asserted-by":"crossref","first-page":"4988","DOI":"10.4049\/jimmunol.1002042","article-title":"Cutting edge: the transcription factor eomesodermin enables CD8+ T cells to compete for the memory cell niche","volume":"185","author":"Banerjee","year":"2010","journal-title":"J. Immunol. (Baltimore, Md: 1950)"},{"issue":"4","key":"10.1016\/j.neuint.2018.11.023_bib5","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1002\/ana.21939","article-title":"Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?","volume":"67","author":"Bar-Or","year":"2010","journal-title":"Ann. Neurol."},{"issue":"12","key":"10.1016\/j.neuint.2018.11.023_bib6","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.tig.2017.09.004","article-title":"The genetics of multiple sclerosis: from 0 to 200 in 50 years","volume":"33","author":"Baranzini","year":"2017","journal-title":"Trends Genet. : TIG (Trends Genet.)"},{"issue":"9","key":"10.1016\/j.neuint.2018.11.023_bib7","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1097\/nen.0b013e3181462841","article-title":"Sodium channel expression within chronic multiple sclerosis plaques","volume":"66","author":"Black","year":"2007","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuint.2018.11.023_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2011.01.059","article-title":"Tumor necrosis factor-alpha (TNF-alpha) augments AMPA-induced Purkinje neuron toxicity","volume":"1386","author":"Bliss","year":"2011","journal-title":"Brain Res."},{"issue":"8","key":"10.1016\/j.neuint.2018.11.023_bib9","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.molmed.2012.06.003","article-title":"Pathogenic features of CD4+CD28- T cells in immune disorders","volume":"18","author":"Broux","year":"2012","journal-title":"Trends Mol. Med."},{"issue":"1","key":"10.1016\/j.neuint.2018.11.023_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaut.2011.11.006","article-title":"CX(3)CR1 drives cytotoxic CD4(+)CD28(-) T cells into the brain of multiple sclerosis patients","volume":"38","author":"Broux","year":"2012","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.neuint.2018.11.023_bib11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/WCO.0b013e3283533a25","article-title":"Mitochondrial changes within axons in multiple sclerosis: an update","volume":"25","author":"Campbell","year":"2012","journal-title":"Curr. Opin. Neurol."},{"issue":"9936","key":"10.1016\/j.neuint.2018.11.023_bib12","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/S0140-6736(13)62242-4","article-title":"Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial","volume":"383","author":"Chataway","year":"2014","journal-title":"Lancet (London, England)"},{"issue":"4","key":"10.1016\/j.neuint.2018.11.023_bib13","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1476-5381.2011.01302.x","article-title":"Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS)","volume":"164","author":"Constantinescu","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.neuint.2018.11.023_bib14","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1177\/1352458514533230","article-title":"The role of microglial activation in disease progression","volume":"20","author":"Correale","year":"2014","journal-title":"Mult. Scler. (Houndmills, Basingstoke, England)"},{"issue":"3","key":"10.1016\/j.neuint.2018.11.023_bib15","first-page":"527","article-title":"Progressive multiple sclerosis: from pathogenic mechanisms to treatment","volume":"140","author":"Correale","year":"2017","journal-title":"Brain: J. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.neuint.2018.11.023_bib16","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.imlet.2012.04.013","article-title":"Role of lymphoid chemokines in the development of functional ectopic lymphoid structures in rheumatic autoimmune diseases","volume":"145","author":"Corsiero","year":"2012","journal-title":"Immunol. Lett."},{"issue":"2","key":"10.1016\/j.neuint.2018.11.023_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.bbadis.2010.06.010","article-title":"Mouse models for multiple sclerosis: historical facts and future implications","volume":"1812","author":"Croxford","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"issue":"4","key":"10.1016\/j.neuint.2018.11.023_bib18","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1084\/jem.20121190","article-title":"Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin","volume":"210","author":"Curran","year":"2013","journal-title":"J. Exp. Med."},{"issue":"24","key":"10.1016\/j.neuint.2018.11.023_bib19","doi-asserted-by":"crossref","first-page":"8381","DOI":"10.1073\/pnas.0803454105","article-title":"Orphan nuclear receptor NR4A2 expressed in T cells from multiple sclerosis mediates production of inflammatory cytokines","volume":"105","author":"Doi","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"4","key":"10.1016\/j.neuint.2018.11.023_bib20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nrneurol.2014.37","article-title":"Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis","volume":"10","author":"Friese","year":"2014","journal-title":"Nat. Rev. Neurol."},{"issue":"Pt 5","key":"10.1016\/j.neuint.2018.11.023_bib21","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1093\/brain\/awp070","article-title":"The relation between inflammation and neurodegeneration in multiple sclerosis brains","volume":"132","author":"Frischer","year":"2009","journal-title":"Brain: J. Neurol."},{"key":"10.1016\/j.neuint.2018.11.023_bib22","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.2147\/DDDT.S122249","article-title":"Spotlight on siponimod and its potential in the treatment of secondary progressive multiple sclerosis: the evidence to date","volume":"11","author":"Gajofatto","year":"2017","journal-title":"Drug Des. Dev. Ther."},{"issue":"4","key":"10.1016\/j.neuint.2018.11.023_bib23","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/14737175.2017.1257385","article-title":"Primary progressive multiple sclerosis: current therapeutic strategies and future perspectives","volume":"17","author":"Gajofatto","year":"2017","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.neuint.2018.11.023_bib24","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3389\/fncel.2012.00038","article-title":"Cell recruitment in the brain during normal aging","volume":"6","author":"Gemechu","year":"2012","journal-title":"Front. Cell. Neurosci."},{"issue":"7145","key":"10.1016\/j.neuint.2018.11.023_bib25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature05911","article-title":"Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls","volume":"447","year":"2007","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neuint.2018.11.023_bib26","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4049\/jimmunol.171.1.368","article-title":"Vulnerability of human neurons to T cell-mediated cytotoxicity","volume":"171","author":"Giuliani","year":"2003","journal-title":"J. Immunol. (Baltimore, Md : 1950)"},{"issue":"Pt 8","key":"10.1016\/j.neuint.2018.11.023_bib27","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/awl075","article-title":"Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research","volume":"129","author":"Gold","year":"2006","journal-title":"Brain: J. Neurol."},{"issue":"8","key":"10.1016\/j.neuint.2018.11.023_bib28","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.4049\/jimmunol.1100037","article-title":"Requirements for eomesodermin and promyelocytic leukemia zinc finger in the development of innate-like CD8+ T cells","volume":"186","author":"Gordon","year":"2011","journal-title":"J. Immunol. (Baltimore, Md: 1950)"},{"issue":"1","key":"10.1016\/j.neuint.2018.11.023_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.immuni.2011.11.016","article-title":"The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation","volume":"36","author":"Gordon","year":"2012","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.neuint.2018.11.023_bib30","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/ana.23974","article-title":"Iron and neurodegeneration in the multiple sclerosis brain","volume":"74","author":"Hametner","year":"2013","journal-title":"Ann. Neurol."},{"issue":"9350","key":"10.1016\/j.neuint.2018.11.023_bib31","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(02)12023-X","article-title":"Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial","volume":"360","author":"Hartung","year":"2002","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.neuint.2018.11.023_bib32","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1146\/annurev.immunol.25.022106.141553","article-title":"Cellular responses to viral infection in humans: lessons from Epstein-Barr virus","volume":"25","author":"Hislop","year":"2007","journal-title":"Annu. Rev. Immunol."},{"issue":"11","key":"10.1016\/j.neuint.2018.11.023_bib33","doi-asserted-by":"crossref","first-page":"e0187215","DOI":"10.1371\/journal.pone.0187215","article-title":"Febuxostat ameliorates secondary progressive experimental autoimmune encephalomyelitis by restoring mitochondrial energy production in a GOT2-dependent manner","volume":"12","author":"Honorat","year":"2017","journal-title":"PloS One"},{"issue":"Pt 9","key":"10.1016\/j.neuint.2018.11.023_bib34","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1093\/brain\/awr182","article-title":"Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis","volume":"134","author":"Howell","year":"2011","journal-title":"Brain: J. Neurol."},{"issue":"6","key":"10.1016\/j.neuint.2018.11.023_bib35","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/nan.12199","article-title":"Extensive grey matter pathology in the cerebellum in multiple sclerosis is linked to inflammation in the subarachnoid space","volume":"41","author":"Howell","year":"2015","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"10","key":"10.1016\/j.neuint.2018.11.023_bib36","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ni.f.215","article-title":"Shouts, whispers and the kiss of death: directional secretion in T cells","volume":"9","author":"Huse","year":"2008","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.neuint.2018.11.023_bib37","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.immuni.2011.02.021","article-title":"Transcription factor Smad-independent T helper 17 cell induction by transforming-growth factor-beta is mediated by suppression of eomesodermin","volume":"34","author":"Ichiyama","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.neuint.2018.11.023_bib38","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.coi.2014.05.003","article-title":"T cells and their cytokines in persistent stimulation of the immune system","volume":"29","author":"Kared","year":"2014","journal-title":"Curr. Opin. Immunol."},{"issue":"6","key":"10.1016\/j.neuint.2018.11.023_bib39","doi-asserted-by":"crossref","first-page":"4196","DOI":"10.4049\/jimmunol.177.6.4196","article-title":"Innate immunity in multiple sclerosis: myeloid dendritic cells in secondary progressive multiple sclerosis are activated and drive a proinflammatory immune response","volume":"177","author":"Karni","year":"2006","journal-title":"J. Immunol. (Baltimore, Md: 1950)"},{"key":"10.1016\/j.neuint.2018.11.023_bib40","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3389\/fimmu.2014.00217","article-title":"Characterization of T-bet and eomes in peripheral human immune cells","volume":"5","author":"Knox","year":"2014","journal-title":"Front. Immunol."},{"issue":"Pt 11","key":"10.1016\/j.neuint.2018.11.023_bib41","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/brain\/awh641","article-title":"Cortical demyelination and diffuse white matter injury in multiple sclerosis","volume":"128","author":"Kutzelnigg","year":"2005","journal-title":"Brain: J. Neurol."},{"issue":"5","key":"10.1016\/j.neuint.2018.11.023_bib42","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.tins.2016.02.001","article-title":"Secondary progression in multiple sclerosis: neuronal exhaustion or distinct pathology?","volume":"39","author":"Larochelle","year":"2016","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuint.2018.11.023_bib43","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1759-1961.2009.00003.x","article-title":"What drives disease in multiple sclerosis: inflammation or neurodegeneration?","volume":"1","author":"Lassmann","year":"2010","journal-title":"Clin. Exp. Neuroimmunol."},{"issue":"Pt A","key":"10.1016\/j.neuint.2018.11.023_bib44","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.expneurol.2013.12.003","article-title":"Multiple sclerosis: lessons from molecular neuropathology","volume":"262","author":"Lassmann","year":"2014","journal-title":"Exp. Neurol."},{"issue":"12","key":"10.1016\/j.neuint.2018.11.023_bib45","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1177\/1352458517729455","article-title":"Targets of therapy in progressive MS","volume":"23","author":"Lassmann","year":"2017","journal-title":"Mult. Scler. (Houndmills, Basingstoke, England)"},{"issue":"2","key":"10.1016\/j.neuint.2018.11.023_bib46","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1750-3639.2007.00064.x","article-title":"The immunopathology of multiple sclerosis: an overview","volume":"17","author":"Lassmann","year":"2007","journal-title":"Brain Pathol."},{"issue":"11","key":"10.1016\/j.neuint.2018.11.023_bib47","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrneurol.2012.168","article-title":"Progressive multiple sclerosis: pathology and pathogenesis","volume":"8","author":"Lassmann","year":"2012","journal-title":"Nat. Rev. Neurol."},{"issue":"7","key":"10.1016\/j.neuint.2018.11.023_bib48","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41590-018-0135-x","article-title":"Reassessing B cell contributions in multiple sclerosis","volume":"19","author":"Li","year":"2018","journal-title":"Nat. Immunol."},{"issue":"Pt 2","key":"10.1016\/j.neuint.2018.11.023_bib49","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/brain\/awq350","article-title":"Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis","volume":"134","author":"Lovato","year":"2011","journal-title":"Brain: J. Neurol."},{"issue":"3","key":"10.1016\/j.neuint.2018.11.023_bib50","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"issue":"10023","key":"10.1016\/j.neuint.2018.11.023_bib51","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(15)01314-8","article-title":"Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial","volume":"387","author":"Lublin","year":"2016","journal-title":"Lancet (London, England)"},{"issue":"6","key":"10.1016\/j.neuint.2018.11.023_bib52","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.immuni.2015.11.008","article-title":"T-box transcription factors combine with the cytokines TGF-beta and IL-15 to control tissue-resident memory T cell fate","volume":"43","author":"Mackay","year":"2015","journal-title":"Immunity"},{"issue":"Pt 4","key":"10.1016\/j.neuint.2018.11.023_bib53","first-page":"1089","article-title":"Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology","volume":"130","author":"Magliozzi","year":"2007","journal-title":"Brain : J. Neurol."},{"issue":"4","key":"10.1016\/j.neuint.2018.11.023_bib54","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/ana.22230","article-title":"A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis","volume":"68","author":"Magliozzi","year":"2010","journal-title":"Ann. Neurol."},{"issue":"2","key":"10.1016\/j.neuint.2018.11.023_bib55","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1750-3639.2007.00067.x","article-title":"Inflammatory cell migration into the central nervous system: a few new twists on an old tale","volume":"17","author":"Man","year":"2007","journal-title":"Brain Pathol."},{"issue":"8","key":"10.1016\/j.neuint.2018.11.023_bib56","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1172\/JCI200112516","article-title":"CD4+CD28- costimulation-independent T cells in multiple sclerosis","volume":"108","author":"Markovic-Plese","year":"2001","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neuint.2018.11.023_bib57","first-page":"954602","article-title":"Cytotoxic CD4 T cells in antiviral immunity","volume":"2011","author":"Marshall","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"issue":"16","key":"10.1016\/j.neuint.2018.11.023_bib58","doi-asserted-by":"crossref","first-page":"8830","DOI":"10.1073\/pnas.94.16.8830","article-title":"Glutamate receptor-mediated toxicity in optic nerve oligodendrocytes","volume":"94","author":"Matute","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"12","key":"10.1016\/j.neuint.2018.11.023_bib59","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1002\/1521-4141(200012)30:12<3623::AID-IMMU3623>3.0.CO;2-F","article-title":"MHC class I-restricted killing of neurons by virus-specific CD8+ T lymphocytes is effected through the Fas\/FasL, but not the perforin pathway","volume":"30","author":"Medana","year":"2000","journal-title":"Eur. J. Immunol."},{"issue":"2","key":"10.1016\/j.neuint.2018.11.023_bib60","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pain.2012.10.022","article-title":"Spinal interleukin-17 promotes thermal hyperalgesia and NMDA NR1 phosphorylation in an inflammatory pain rat model","volume":"154","author":"Meng","year":"2013","journal-title":"Pain"},{"issue":"49","key":"10.1016\/j.neuint.2018.11.023_bib61","doi-asserted-by":"crossref","first-page":"15397","DOI":"10.1523\/JNEUROSCI.4339-09.2009","article-title":"Cytotoxic CD8+ T cell-neuron interactions: perforin-dependent electrical silencing precedes but is not causally linked to neuronal cell death","volume":"29","author":"Meuth","year":"2009","journal-title":"J. Neurosci.: Off. J. Soc. Neurosci."},{"issue":"8","key":"10.1016\/j.neuint.2018.11.023_bib62","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1177\/1352458508092809","article-title":"Expansion of CD4+CD28- T cells producing high levels of interferon-{gamma} in peripheral blood of patients with multiple sclerosis","volume":"14","author":"Miyazaki","year":"2008","journal-title":"Mult. Scler. (Houndmills, Basingstoke, England)"},{"issue":"6","key":"10.1016\/j.neuint.2018.11.023_bib63","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1096\/fj.07-099499","article-title":"Interferon-gamma directly induces neurotoxicity through a neuron specific, calcium-permeable complex of IFN-gamma receptor and AMPA GluR1 receptor","volume":"22","author":"Mizuno","year":"2008","journal-title":"Faseb. J. : Off. Publ. Feder. Amer. Soc. Exper. Biol."},{"issue":"3","key":"10.1016\/j.neuint.2018.11.023_bib64","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMoa1606468","article-title":"Ocrelizumab versus placebo in primary progressive multiple sclerosis","volume":"376","author":"Montalban","year":"2017","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.neuint.2018.11.023_bib65","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/BJ20081386","article-title":"How mitochondria produce reactive oxygen species","volume":"417","author":"Murphy","year":"2009","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.neuint.2018.11.023_bib66","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nm.2324","article-title":"A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"17","author":"Nikic","year":"2011","journal-title":"Nat. Med."},{"issue":"9232","key":"10.1016\/j.neuint.2018.11.023_bib67","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S0140-6736(00)02659-3","article-title":"Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL)","volume":"356","author":"Nitsch","year":"2000","journal-title":"Lancet (London, England)"},{"issue":"10","key":"10.1016\/j.neuint.2018.11.023_bib68","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1212\/01.WNL.0000146958.77317.3E","article-title":"Interferon beta-1b in secondary progressive MS: results from a 3-year controlled study","volume":"63","author":"Panitch","year":"2004","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neuint.2018.11.023_bib69","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4110\/in.2016.16.2.126","article-title":"Effect of IL-4 on the development and function of memory-like CD8 T cells in the peripheral lymphoid tissues","volume":"16","author":"Park","year":"2016","journal-title":"Immune Network"},{"issue":"5647","key":"10.1016\/j.neuint.2018.11.023_bib70","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1126\/science.1090148","article-title":"Control of effector CD8+ T cell function by the transcription factor Eomesodermin","volume":"302","author":"Pearce","year":"2003","journal-title":"Science (New York, NY)"},{"issue":"1","key":"10.1016\/j.neuint.2018.11.023_bib71","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-065X.2012.01126.x","article-title":"Mechanisms regulating regional localization of inflammation during CNS autoimmunity","volume":"248","author":"Pierson","year":"2012","journal-title":"Immunol. Rev."},{"issue":"9139","key":"10.1016\/j.neuint.2018.11.023_bib72","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0140-6736(98)10039-9","article-title":"Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS","volume":"352","year":"1998","journal-title":"Lancet (London, England)"},{"issue":"11","key":"10.1016\/j.neuint.2018.11.023_bib73","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1212\/WNL.56.11.1496","article-title":"Randomized controlled trial of interferon- beta-1a in secondary progressive MS: clinical results","volume":"56","year":"2001","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neuint.2018.11.023_bib74","doi-asserted-by":"crossref","first-page":"e56595","DOI":"10.1371\/journal.pone.0056595","article-title":"Nuclear receptor NR4A2 orchestrates Th17 cell-mediated autoimmune inflammation via IL-21 signalling","volume":"8","author":"Raveney","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.neuint.2018.11.023_bib75","doi-asserted-by":"crossref","first-page":"8437","DOI":"10.1038\/ncomms9437","article-title":"Eomesodermin-expressing T-helper cells are essential for chronic neuroinflammation","volume":"6","author":"Raveney","year":"2015","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.neuint.2018.11.023_bib76","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/ng2032","article-title":"Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis","volume":"39","author":"Rioux","year":"2007","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.neuint.2018.11.023_bib77","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.nbd.2004.10.007","article-title":"Microarray analysis identifies an aberrant expression of apoptosis and DNA damage-regulatory genes in multiple sclerosis","volume":"18","author":"Satoh","year":"2005","journal-title":"Neurobiol. Dis."},{"issue":"7359","key":"10.1016\/j.neuint.2018.11.023_bib78","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature10251","article-title":"Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis","volume":"476","author":"Sawcer","year":"2011","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.neuint.2018.11.023_bib79","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.4049\/jimmunol.160.3.1532","article-title":"Expansion of autoreactive T cells in multiple sclerosis is independent of exogenous B7 costimulation","volume":"160","author":"Scholz","year":"1998","journal-title":"J. Immunol. (Baltimore, Md: 1950)"},{"issue":"4","key":"10.1016\/j.neuint.2018.11.023_bib80","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.coi.2013.07.006","article-title":"A comparative review of aging and B cell function in mice and humans","volume":"25","author":"Scholz","year":"2013","journal-title":"Curr. Opin. Immunol."},{"issue":"2","key":"10.1016\/j.neuint.2018.11.023_bib81","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","article-title":"Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis","volume":"14","author":"Serafini","year":"2004","journal-title":"Brain Pathol."},{"issue":"9","key":"10.1016\/j.neuint.2018.11.023_bib82","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/jnen\/nlw063","article-title":"RORgammat expression and lymphoid neogenesis in the brain of patients with secondary progressive multiple sclerosis","volume":"75","author":"Serafini","year":"2016","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"4","key":"10.1016\/j.neuint.2018.11.023_bib83","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.immuni.2016.09.010","article-title":"Foxo3 transcription factor drives pathogenic T helper 1 differentiation by inducing the expression of eomes","volume":"45","author":"Stienne","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.neuint.2018.11.023_bib84","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fimmu.2017.00194","article-title":"CD4 CTL, a cytotoxic subset of CD4(+) T cells, their differentiation and function","volume":"8","author":"Takeuchi","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.neuint.2018.11.023_bib85","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1196\/annals.1361.066","article-title":"Premature immunosenescence in rheumatoid arthritis and multiple sclerosis patients","volume":"1051","author":"Thewissen","year":"2005","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"10","key":"10.1016\/j.neuint.2018.11.023_bib86","doi-asserted-by":"crossref","first-page":"6514","DOI":"10.4049\/jimmunol.179.10.6514","article-title":"CD4+CD28null T cells in autoimmune disease: pathogenic features and decreased susceptibility to immunoregulation","volume":"179","author":"Thewissen","year":"2007","journal-title":"J. Immunol. (Baltimore, Md: 1950)"},{"issue":"13","key":"10.1016\/j.neuint.2018.11.023_bib87","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1177\/1352458516667568","article-title":"MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: a randomised, double-blind, placebo-controlled study","volume":"22","author":"Tourbah","year":"2016","journal-title":"Mult. Scler. (Houndmills, Basingstoke, England)"},{"issue":"12","key":"10.1016\/j.neuint.2018.11.023_bib88","first-page":"1583","article-title":"Progressive MS trials: lessons learned","volume":"23","author":"Tur","year":"2017","journal-title":"Mult"},{"issue":"4","key":"10.1016\/j.neuint.2018.11.023_bib89","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0166-2236(99)01533-7","article-title":"A new concept in neurodegeneration: TNFalpha is a silencer of survival signals","volume":"23","author":"Venters","year":"2000","journal-title":"Trends Neurosci."},{"issue":"Pt 2","key":"10.1016\/j.neuint.2018.11.023_bib90","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/brain\/awq337","article-title":"Acid-sensing ion channel 1 is involved in both axonal injury and demyelination in multiple sclerosis and its animal model","volume":"134","author":"Vergo","year":"2011","journal-title":"Brain : J. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.neuint.2018.11.023_bib91","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0006-8993(00)03238-8","article-title":"Interferon-gamma-induced changes in synaptic activity and AMPA receptor clustering in hippocampal cultures","volume":"896","author":"Vikman","year":"2001","journal-title":"Brain Res."},{"issue":"3","key":"10.1016\/j.neuint.2018.11.023_bib92","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/ana.21719","article-title":"Lower motor neuron loss in multiple sclerosis and experimental autoimmune encephalomyelitis","volume":"66","author":"Vogt","year":"2009","journal-title":"Ann. Neurol."},{"issue":"8","key":"10.1016\/j.neuint.2018.11.023_bib93","doi-asserted-by":"crossref","first-page":"e43950","DOI":"10.1371\/journal.pone.0043950","article-title":"Granzyme B-induced neurotoxicity is mediated via activation of PAR-1 receptor and Kv1.3 channel","volume":"7","author":"Wang","year":"2012","journal-title":"PloS One"},{"issue":"12","key":"10.1016\/j.neuint.2018.11.023_bib94","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1038\/nrn2023","article-title":"Axonal conduction and injury in multiple sclerosis: the role of sodium channels","volume":"7","author":"Waxman","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"issue":"3","key":"10.1016\/j.neuint.2018.11.023_bib95","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/ana.21640","article-title":"The challenge of multiple sclerosis: how do we cure a chronic heterogeneous disease?","volume":"65","author":"Weiner","year":"2009","journal-title":"Ann. Neurol."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018618303024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018618303024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T09:47:06Z","timestamp":1759312026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018618303024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":95,"alternative-id":["S0197018618303024"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2018.11.023","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eomes-expressing T-helper cells as potential target of therapy in chronic neuroinflammation","name":"articletitle","label":"Article Title"},{"value":"Neurochemistry International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuint.2018.11.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104348"}}